Biocorp: AMF gives go-ahead to proposed simplified tender offer
The offeror irrevocably undertakes to acquire, at a unit price of 35 euros, all the 1,094.726 shares that it does not hold, representing 24.81% of the share capital and 24.72% of the voting rights of this company.
Following the closing of the offer, and if the required conditions are met, the initiator intends to request the implementation of a squeeze-out for the Biocorp shares not tendered to the offer, at the same price.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction